Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1610 | Thyroid (non-cancer) | ICEECE2012

Impaired absorption of thyroxine in occult celiac disease

Virili C. , Santaguida M. , Cellini M. , Gatto I. , Gargiulo P. , Centanni M.

Some case report suggested that increased need for thyroxine may occur in overt celiac disease (CD). However, overt CD (with typical gastrointestinal symptoms) only represents 10 to 20% of cases of CD, being the majority represented by the atypical CD and other occult forms, in which extra intestinal symptoms prevail. Few data on the need for oral T4 in patients with occult CD are available. In this study we analyzed the replacement T4 dose in 68 hypothyr...

ea0026p288 | Pituitary | ECE2011

Pegvisomant therapy in acromegaly: a multicenter observational study

Bianchi A , Tilaro L , Valentini F , Gargiulo P , Poggi M , Baldelli R , Passeri M , De Marinis L

Patients with acromegaly resistant to conventional drug treatment currently can advantage with GH-receptor antagonist pegvisomant. To date, at doses up to 40 mg/day, it is capable of normalizing circulating IGF1 in until 97% of patients. Here we present the multicenter experience in Rome with Pegvisomant as a therapeutic option in acromegaly. This is an observational study including a total of 61 patients (21 males and 40 females) treated with pegvisomant for up to 7 years. Of...

ea0011p86 | Clinical case reports | ECE2006

A case of bacterial endocarditis in a patient with acromegaly

Bassotti G , Di Sarra D , Pietrobono D , D’Amico T , Gargiulo P , Tamburrano G

Objective and importance: Among pathologies associated with acromegaly, have great importance both colon benignant neoformations such polyposis, and cardiovascular complications such as miocardic hypertrophy, arterial hypertension, coronaropathy and valvulopathy.Clinical presentation: We report a case of 74-years-old woman with acromegaly, diabetes mellitus type II and hyperthyroidism, who was admitted at our clinic with symptoms of chronic febricula wit...

ea0011p89 | Clinical case reports | ECE2006

A case of adult GH deficit in a woman with Autoimmune Polyendocrine Syndrome type II

Pietrobono D , Bassotti G , Diacono F , Iuorio R , Mercuri V , Gargiulo P

We report a case of a 53 years old woman who presented asthenia, cramps, cutaneous hyperpigmentation, nausea, vomiting, vague and non-specific epigastric abdominal pain, weight loss and hypotension. She was diagnosed with Addison’s disease because biochemical data were indicative for autoimmune adrenal failure (positivity for adrenal cortex antibodies). Nevertheless during the following 9 years the patient began to note the progressive reduction of pubic and axillary hair...

ea0011p459 | Endocrine tumours and neoplasia | ECE2006

Role of family history for diabetes mellitus in determining insulin resistance in acromegalic patients

Diacono F , Pietrobono D , Bassotti G , Borgognoni L , Di Sarra D , Iuorio R , Gargiulo P , Tamburrano G

Objective: Acromegaly is a rare pituitary disease due to excessive secretion of GH. Insulin resistance, impaired glucose tolerance (IGT) and diabetes mellitus (DM) are common features in acromegaly. Seventy-four active acromegalic patients were retrospectively evaluated in order to determine the impact of family history for diabetes mellitus on glucose tolerance, insulin resistance and beta-cell function.Patients and methods: We studied 74 patients with ...

ea0014p40 | (1) | ECE2007

PED levels are increased in peripheral blood leucocytes from euglycaemic subjects at-risk of type 2 diabetes

Valentino Rossella , Lupoli Gelsy Arianna , Formisano Pietro , Esposito Iolanda , Alberobello Anna Teresa , Perfetti Anna , Cirillo Michele , Gennarelli Nicola , Gargiulo Giovanna , Lobello Roberto , Beguinot Francesco

Background: Phosphoprotein enriched in diabetes (PED) is a scaffold protein widely produced in different tissues; it is involved in multiple cellular functions, including insulin-regulated glucose transport. Previous findings showed that in individuals with type 2 diabetes (T2D) the PED gene is overexpressed in skeletal muscle (SM) and adipose tissue (AT), both target tissues for insulin activity. Our group has recently evidenced that PED protein is also expressed in periphera...